MIRA INFORM REPORT

 

 

 

Report Date :

17.06.2008

 

IDENTIFICATION DETAILS

 

Name :

ERAWAT PHARMA LIMITED

 

 

Registered Office :

302, Anu Apartments, 21/22, Shankar Nagar, Saket Anex, Indore – 452 018, Madhya Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

01.03.1993

 

 

Com. Reg. No.:

7538

 

 

CIN No.:

[Company Identification No.]

U02423MP1993PLC007538

 

 

IEC No.:

1104004011

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BPLE00157D

 

 

Legal Form :

A Closely Held Public Limited Liability Company.

 

 

Line of Business :

Manufacturer of Empty Hard Gelatin Capsules. 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 144000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having satisfactory track. Trade relations are fair. General financial position is moderate. Payments are reported as usually correct and as per commitments. The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Mangesh Gupta

Designation :

Chartered Accountant

Contact No.:

91-9406827176

Date :

11.06.2008

 

 

LOCATIONS

 

Registered Office :

302, Anu Apartments, 21/22, Shankar Nagar, Saket Anex, Indore – 452 018, Madhya Pradesh, India

Tel. No.:

91-731-2566020/ 2556036/2566024

Mobile No.:

91-9826033179

Fax No.:

91-731-2560929

E-Mail :

info@erawatgroup.com

mk.sharma@erawatgroup.com

hema@erawatgroup.com

erqwatpharma@ancharnet.in

Website :

http://www.erawat.com

Area :

800 sq. ft.

Location :

Owned

 

 

Factory :

512, Industrial Area No. 3, Pithampura, District Dhar – 454 744, Madhya Pradesh, India

Tel. No.:

91-7292-256243

E-Mail :

erawatpharma@sancharnet.in

Area :

80000 sq. ft.

Location :

Leased

 

 

DIRECTORS

 

Name :

Mr. Hem Chandra Jain

Designation :

Managing Director

Address :

29-30, Utkarsh Vihar Colony, Indore, Madhya Pradesh, India 

Date of Birth/Age :

57 Years

Qualification :

M. E. and B. E. (Mech)

Experience :

30 Years

Profile :

Mr. H.C. Jain is Managing Director of Erawat Pharma Limited. He is a Mechanical Engineer with around 30 years of experience in engineering & empty gelatin capsules manufacturing, a rare combination.

 

 

Name :

Mr. Abhishek Jain

Designation :

Director

Address :

29-30, Utkarsh Vihar Colony, Indore, Madhya Pradesh, India 

Date of Birth/Age :

30 Years

Qualification :

B. E. (Mech)

Experience :

8 Years

Profile :

B.E. (Mech.) having 6 years rich experience of manufacturing and management of the same company.

 

 

Name :

Mr. Mukesh Shah

Designation :

Director

Address :

3 The Drive Vally, Middle Sex, UK

Date of Birth/Age :

58 Years

Experience :

30 Years

 

 

Name :

Mr. Vasant H. Solanki

Designation :

Director

Address :

Deepak Jyoti Tower, Ambewadi, Mumbai, Maharashtra, India

Date of Birth/Age :

57 Years

Qualification :

M. E. (Mech)

Experience :

31 Years

Profile :

B.E. (Mech.); M.Tech. (Design) having more than 31 years of experience as Designer. He has been managing technical departments and technology in Senior Cadre.

 

 

Name :

Mr. Vinod Kataria

Designation :

Director

Address :

B-5, Green Valley, Navrangpura, Ahmedabad, Gujarat, India

Date of Birth/Age :

55 Years

Qualification :

B. E. (Electrical)

Experience :

32 Years

Profile :

B.E. (Electrical) having 32 years of experience in General Management & Project Consultant.

 

 

Name :

Mr. D S Sodhi

Designation :

Director

Address :

42, Kamlesh, Sher-E-Punjab Society, Mumbai, Maharashtra, India

Date of Birth/Age :

60 Years

Qualification :

B. E. (Mech)

Experience :

36 Years

Profile :

B.E. (Mech.) having around 36 years of experience in manufacturing, marketing & general management at top level.

 

 

Name :

Mr. Raj Damodar Kirtani

Designation :

Director

Address :

Bengali Square, Indore, Madhya Pradesh, India 

Date of Birth/Age :

57 Years

Qualification :

LLB, IFCWA, AIAM, AMIMA, DCP M. B. I.

Experience :

30 Years

Profile :

L.L.B, I.F.C.W.A. AIAM, AMIMA D.C.P. Having 30 years experience in Finance & Cost Accounting.

 

 

KEY EXECUTIVES

 

Name :

Mr. Amit Jain

Designation :

Executive Officer (Sales and Marketing)

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2005

 

Names of Shareholders

 

No. of Shares

 

 

 

Mrs. Meena Jain

 

49500

Mr. Hem Chandra Jain

 

209200

Mr. Abhishek Jain

 

102700

Mr. Vasant H Solanki

 

457500

Mr. Birendra Kumar Jain

 

18800

Mr. Ravindra Kumar Jain 

 

10500

Mr. Nirmal Kumar Jain

 

15200

Mrs. Kanta Devi Jain

 

15000

Mr. Harish Kumar Jain

 

7000

Mr. Hiramani Jain

 

3000

Hem Chandra Jain – HUF

 

55800

Jhanjhari Sons Leasing and Investment Private Limited

 

600700

Erawat Engineering Private Limited

 

571000

Mrs. Anita Jain

 

10500

Mrs. Sushila Solanki

 

72500

Mr. Mayur Shah and Mr. Gopal M Shah

 

30000

Mr. Savant Tongya

 

1500

Mr. Santosh Tongya

 

1500

Emralled Finance

 

150000

Mr. C P Mishra

 

6000

Mr. Mayur and Mr. Mukesh Shah

 

25000

Mr. Vinod Kataria

 

15000

Mr. L K Bhandari

 

40000

Mr. R B Gajra

 

150000

Mrs. Rita R Gajra

 

150000

R B Gajra – HUF

 

200000

Mr. Abhijeet Jain

 

102700

Mrs. Nancy Jain

 

54500

Mrs. Maina Jain

 

10000

Mr. Rahul Jain

 

5000

Mr. Kapil Jain

 

5000

Mr. Amit Jain

 

5000

Zankar Leasing and Financing Private Limited

 

24000

Strerred Assets Stablization Funds

 

600000

Mr. Gopal Das Montri

 

10000

Mrs. Hema Vyas

 

17500

Mr. Abhay Sharma

 

10000

Mrs. Krishna Sharma 

 

10000

Mr. Manoj Sharma

 

17500

Mr. Sambhulal Rathi

 

10000

Mrs. Manish Maheshwari

 

6700

Mrs. Girija Shankar

 

14200

Mr. Krishna Shankar

 

14200

Mr. Amrish Maheshwari

 

6700

Mr. Aditya Vyas

 

14200

Mr. Sumit Jhawar

 

6700

Mrs. Anjani Sharma

 

17500

Mr. Vinod Sharma

 

20800

Mr. Mohanlal Sharma

 

10000

Sagittarious Securities and Finance Limited Trading Company

 

20000

Mrs. Sarita Sharma

 

7500

Mohanlal Anandilal Sharma - HUF

 

7500

Girija Shankar Anandilal Sharma – HUF

 

7500

Balaji Resource and Trading Limited

 

35000

Anant Machines and Equipment Private Limited

 

219700

Mr. Amit Jain

 

102700

Preferences Shares

 

 

Mr. Hem Chandra Jain

 

10000

Mrs. Meena Jain

 

10000

Mr. Abhishek Jain

 

7500

Mr. Abhijeet Jain

 

7500

Mr. Amit Jain

 

2500

Hem Chandra Jain - HUF

 

10000

Mrs. Nancy Jain

 

12500

Total

 

4420000

 

Equity Share Breakup (Percentage of Total Equity)

As on 29.09.2007

 

Category

 

 

Percentage

Foreign holdings (Foreign institutional investor(s), Foreign Companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas corporate bodies or Others

 

4.00

Bodies corporate (Not mentioned above)

 

31.00

Directors or relatives of directors

 

39.00

Other top fifty (50) shareholders (Other than Listed above)

 

15.00

Nationalised or other banks

 

11.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Empty Hard Gelatin Capsules. 

 

 

Products :

Empty Hard Gelatin Capsules 

 

 

Exports :

 

Products :

Empty Hard Gelatin Capsules

Countries :

Sri Lanka, Malaysia, Bangladesh  Netherlands, Africa, Philippines, Jakarta, Dubai, Nepal.

 

PRODUCTION STATUS

 

Particulars

 

 

Installed Capacity

Actual Production

 

 

 

 

 

Empty Hard Gelatin Capsules

 

 

1600 million capsule p.a.

12780.31 lacs

 

GENERAL INFORMATION

 

No. of Employees :

Around 70

 

 

Bankers :

Þ      Bank of India

      Palajia Branch, Indore, Madhya Pradesh, India

 

Þ      Industrial Development Bank of India

 

Þ      ICICI Bank Limited

 

 

Facilities :

Credit Limit: Rs. 2.700 millions

 

Secured Loans

(Rs. in millions)

 

31.03.2006

SASF (IDBI)

(secured by first charges on land and building plant and machinery and other fixed assets installed or to be installed and further secured by personal guarantee of Directrors namely Mr. H C Jain, Mr. V H Solanki, Mr. R D kirtani and Mr. Vinod Kataria)

00.000

Bank of India

(against hypothecation of book debts)

0.706

Bank of India

(against hypothecation of stock)

Cash Credit from Bank of India

(secured by hypothecation of stock and book debts and equitable mortgage of flat and plot in the name of Mr. H C Jain and Mrs. Meena Jain and further secured by personal guarantee of Mr. H C Jain and Mrs. Meena Jain, Mr. V H Solanki nd Mr. Vinod Kataria

1.938

ICICI Bank Limited

(hypothecation of Maruti 800)

0.165

City Corporation Maruti Finance Limited

(Hypothecation of Maruti Alto)

0.123

 

Unsecured Loans

(Rs. in millions)

 

31.03.2006

Deferement of MPCT

6.088

Deferement of CST

8.901

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Mahesh Virendra and Company

Mahesh Gupta

Chartered Accountants

Address :

59A, Saket Nagar, G-1, Baldev Apartment, Indore, Madhya Pradesh, India

Tel. No.:

91-731-2565731/ 2566020

Mobile No.:

91-9406827176

 

CAPITAL STRUCTURE

 

As on 22.09.2007

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5400000

Equity Shares

Rs. 10/- each

Rs. 54.000 Millions

200000

Preferences Shares

Rs. 10/- each

Rs. 2.000 Millions

 

Total

 

Rs. 56.000 Millions

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4360000

Equity Shares

Rs. 10/- each

Rs. 43.600 Millions

60000

Preferences Shares

Rs. 10/- each

Rs. 0.600 Million

 

Total

 

Rs. 44.200 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

 

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

44.200

34.200

25.550

2] Share Application Money

2.650

2.820

2.650

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

[4.181]

(1.045)

(70.052)

NETWORTH

42.669

35.975

(41.852)

LOAN FUNDS

 

 

 

1] Secured Loans

10.663

27.933

154.396

2] Unsecured Loans

17.628

14.989

13.503

TOTAL BORROWING

28.291

42.922

167.899

DEFERRED TAX LIABILITIES

12.959

13.213

0.000

 

 

 

 

TOTAL

83.919

92.110

126.047

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

62.263

66.036

63.806

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

25.828

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

10.739

12.906

11.301

 

Sundry Debtors

22.735

19.218

23.938

 

Cash & Bank Balances

0.108

0.242

0.385

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

2.217

3.543

8.350

Total Current Assets

35.799

35.909

43.974

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

15.085

10.957

7.582

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

15.085

10.957

7.582

Net Current Assets

20.714

24.952

36.392

 

 

 

 

MISCELLANEOUS EXPENSES

0.942

1.122

0.021

 

 

 

 

TOTAL

83.919

92.110

126.047

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2007

 

31.03.2006

31.03.2005

Sales Turnover

77.795

68.312

83.539

Other Income

0.340

0.207

0.155

Total Income

78.135

68.519

83.694

 

 

 

 

Profit/(Loss) Before Tax

(3.389)

(108.048)

(13.590)

Provision for Taxation

(0.254)

(39.041)

(6.311)

Profit/(Loss) After Tax

(3.135)

(69.007)

(7.279)

 

 

 

 

Earnings in Foreign Currency :

 

 

 

 

Export Earnings

0.000

1.264

0.000

 

 

 

 

Expenditures :

 

 

 

 

Cost of Goods Sold

0.000

0.000

0.000

 

Manufacturing Expenses

20.028

16.498

23.034

 

Administrative Expenses

7.964

9.021

10.944

 

Raw Material Consumed

39.950

35.047

40.728

 

Interest

0.000

0

0.000

 

Depreciation & Amortization

4.986

4.743

4.483

 

Employee Cost

7.300

6.219

5.034

 

Financial Cost

0.729

0.204

19.782

 

Preliminary Expenses

0.010

0.010

0.010

 

Deferred Revenue Expenses

0.235

0.000

0.000

 

Fringe Benefit Tax

0.060

0.091

0.000

 

Increase or decrease of stocks

0.262

0.547

[6.731]

 

Other Expenditure

0.000

104.187

0.000

Total Expenditure

81.524

176.567

104.015

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

 

31.03.2006

31.03.2005

PAT / Total Income

(%)

[4.34]

[100.71]

(8.65)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

[4.36]

[158.16]

(16.17)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

[3.76]

[105.98]

(12.60)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

[0.08]

[3.00]

(4.19)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.01

1.49

(3.19)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.37

3.28

5.79

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Trade References:

 

Þ      Hemas Healthcare

Þ      Prime Pharmaceuticals

Þ      Eskayei

Þ      Caps and Chemicals, Dewas Naka, Indore, Madhya Pradesh, India

Þ      Anil Enterprises, 225 Hemilton Road, Indore, Madhya Pradesh, India

Þ      Syncom Formulation, Dawa Bazar, Indore, Madhya Pradesh, India

Þ      Aristo Pharmaceutical Limited, Mumbai

Þ      Cadila Pharmceutical Limited, Vadodhara

 

 

The Company’s Fixed Assets of important value includes:

 

Þ      Lease Hold Land

Þ      Building

Þ      Furniture and Fixtures

Þ      Electrical Installations

Þ      Plant and Machinery

Þ      Computer

Þ      Lab Equipments

Þ      Car

Þ      Utensialls

Þ      Tata Sumo

Þ      Alto Car

Þ      Pager 

Þ      EPABX and Telephone

Þ      ETP Plant Poll

Þ      Maturi 800Car

 

As Per Web

 

Introduction

 

Subject is an integral part of Erawat Group and is involved exclusively in manufacturing and marketing of "Empty Hard Gelatin Capsules". EPL is launched and handled by well-experienced team of technical and professional people committed to provide the Domestic and International Pharmaceutical Industry with Capsules best suited for "High Speed Automatic Filling Machines".

 

History

 

The group came in existence with start of an Engineering Industry named Erawat Engineering Private Limited in 1989 at Pithampur (Madhya Pradesh) In this unit we have developed Automatic Capsule Making Plant, Capsule Printing Machines and Equipments for research in Center of Advance Technology (Department of Atomic Energy) as per their demand. Erawat Engineering has also supplied Automatic Capsule making plants to other capsule manufacturers.

 

Locations

 

Subject is located at Pithumpur Industrial Area, near Indore, the Industrial Capital of Madhya Pradesh. This place is well connected to all parts of the country and the world.

Their unit is situated right beside ICD (Inland Container Depot) of Indian Container Corporation (CONCOR), which is a dry port within Pithumpur Industrial Estate. This facilitates custom clearance and export of products from here thus reducing the delivery time considerably. The Industrial Estate is having a culture and environment of quality due to presence of large industrial houses with latest technology from within and through collaboration with many developed countries.

 

Clients

Þ      Ajanta Pharma Limited, Mumbai

Þ      Alpa Laboratories Limited, Pigdamber

Þ      Aristo Pharmaceuticals L Imited, Mumbai

Þ      Aurobindo Pharma Limited, Hyderabad

Þ      Dabur India Limited, Sahibabad

Þ      Cadila Healthcare Limited, Ahmedabad

Þ      Cadila Pharmaceuticals Limited, Ahmedabad

Þ      Cipla

Þ      Dindayal Aushadhi Pvt. Limited, Gwalior

Þ      Elysium Pharmaceuticals Limited, Baroda

Þ      Eros Pharma Limited (Micro Labs), Bangalore

Þ      Gracure Pharmaceuticals Limited, Delhi

Þ      Hindustan Antibiotics Limited, Pune

Þ      Ipca

Þ      Karnataka Antibiotics And Pharma. Ltd., Bangalore

Þ      Leben Laboratories Pvt. Limited, Akola

Þ      Litaka Pharmaceuticals Limited, Pune

Þ      Mission Pharmaceuticals Limited, Mumbai

Þ      Medibios Laboratories (P) Limited, Mumbai (Emil)

Þ      Rajasthan Drugs And Pharma Limited, Jaipur

Þ      Sarabhai Chemicals, Baroda

Þ      S.G. Pharmaceuticals, Baroda

Þ      Sidmak Laboratories (India) Limited, Valsad

Þ      Srushti Pharmaceuticals Limited, Bangalore

Þ      Stallion Laboratories Pvt. Limited, Ahmedabad

Þ      Syncom Formulations (India) Limited, Indore

Þ      Skant

Þ      Ttk Healthcare Limited, Chennai

Þ      Vasu Pharmaceuticals Pvt. Limited, Baroda

Þ      Unjha Formulations Limited, Unjha

 

 

 

Bankers Charges Report as per Registry

 

 

Name of the company

ERAWAT PHARMA LIMITED

Presented By

Mr. Hemchandra Jain

1) Date and description of instrument creating the change

10.02.1998 An  Agreement of hypothecation of movable stocks

2) Amount secured by the charge/amount owing on the securities of charge

Rs. 2.000 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

All the tangible movable assets of the Company including in particular all stocks of raw materials such as gelatine. Food colors additives and finished goods such as empty Capsule of different sizes and colors stocks in process, stores, spares, Chemical etc. Wheresover situated and /or in transit.

4) Gist of the terms and conditions and extent and operation of the charge.

First charge by way of hypothecation of tangible movable assets mentioned in items No. 3 and such assets of the nature described in item No. 3 on are or may at any time be in possession or power of the Company to secure a demand cash credit of Rs. 2.000 Millions plus interest at the rate of 17% p.a. with quarterly rests or at such other rates as may be the bank from time to time with power to the

5) Name and Address and description of the person entitled to the charge.

Bank of India, Palasia Branch, 575/1, M.G. Road, Indore, Madhya Pradesh

6) Date  and brief description of instrument modifying the charge

Not Applicable

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Not Applicable

 

 

 

 

 

 

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.42.90

UK Pound

1

Rs.83.76

Euro

1

Rs.65.99

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions